vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and NAPCO SECURITY TECHNOLOGIES, INC (NSSC). Click either name above to swap in a different company.

NAPCO SECURITY TECHNOLOGIES, INC is the larger business by last-quarter revenue ($48.2M vs $47.7M, roughly 1.0× IRONWOOD PHARMACEUTICALS INC). NAPCO SECURITY TECHNOLOGIES, INC runs the higher net margin — 28.0% vs -4.8%, a 32.8% gap on every dollar of revenue. On growth, NAPCO SECURITY TECHNOLOGIES, INC posted the faster year-over-year revenue change (12.2% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $14.5M). Over the past eight quarters, NAPCO SECURITY TECHNOLOGIES, INC's revenue compounded faster (-1.1% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

Napco Security Technologies, Inc. was set up in 1969 and now is based in Amityville, New York. The company focuses on security products, such as electronic locking devices, alarm systems, and building access control systems. The company was formerly known as Napco Security Systems, Inc.

IRWD vs NSSC — Head-to-Head

Bigger by revenue
NSSC
NSSC
1.0× larger
NSSC
$48.2M
$47.7M
IRWD
Growing faster (revenue YoY)
NSSC
NSSC
+59.5% gap
NSSC
12.2%
-47.3%
IRWD
Higher net margin
NSSC
NSSC
32.8% more per $
NSSC
28.0%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$60.1M more FCF
IRWD
$74.6M
$14.5M
NSSC
Faster 2-yr revenue CAGR
NSSC
NSSC
Annualised
NSSC
-1.1%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
IRWD
IRWD
NSSC
NSSC
Revenue
$47.7M
$48.2M
Net Profit
$-2.3M
$13.5M
Gross Margin
58.6%
Operating Margin
14.3%
30.6%
Net Margin
-4.8%
28.0%
Revenue YoY
-47.3%
12.2%
Net Profit YoY
-200.9%
29.0%
EPS (diluted)
$0.01
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
NSSC
NSSC
Q4 25
$47.7M
$48.2M
Q3 25
$122.1M
$49.2M
Q2 25
$85.2M
$50.7M
Q1 25
$41.1M
$44.0M
Q4 24
$90.5M
$42.9M
Q3 24
$91.6M
$44.0M
Q2 24
$94.4M
$50.3M
Q1 24
$74.9M
$49.3M
Net Profit
IRWD
IRWD
NSSC
NSSC
Q4 25
$-2.3M
$13.5M
Q3 25
$40.1M
$12.2M
Q2 25
$23.6M
$11.6M
Q1 25
$-37.4M
$10.1M
Q4 24
$2.3M
$10.5M
Q3 24
$3.6M
$11.2M
Q2 24
$-860.0K
$13.5M
Q1 24
$-4.2M
$13.2M
Gross Margin
IRWD
IRWD
NSSC
NSSC
Q4 25
58.6%
Q3 25
56.6%
Q2 25
52.8%
Q1 25
57.2%
Q4 24
57.0%
Q3 24
55.9%
Q2 24
55.3%
Q1 24
53.8%
Operating Margin
IRWD
IRWD
NSSC
NSSC
Q4 25
14.3%
30.6%
Q3 25
61.8%
27.7%
Q2 25
53.2%
23.8%
Q1 25
-70.7%
25.4%
Q4 24
34.8%
26.0%
Q3 24
28.0%
26.9%
Q2 24
26.5%
27.7%
Q1 24
14.7%
29.4%
Net Margin
IRWD
IRWD
NSSC
NSSC
Q4 25
-4.8%
28.0%
Q3 25
32.8%
24.7%
Q2 25
27.7%
22.9%
Q1 25
-90.9%
23.0%
Q4 24
2.5%
24.4%
Q3 24
4.0%
25.4%
Q2 24
-0.9%
26.9%
Q1 24
-5.6%
26.8%
EPS (diluted)
IRWD
IRWD
NSSC
NSSC
Q4 25
$0.01
$0.38
Q3 25
$0.23
$0.34
Q2 25
$0.14
$0.33
Q1 25
$-0.23
$0.28
Q4 24
$0.03
$0.28
Q3 24
$0.02
$0.30
Q2 24
$-0.01
$0.36
Q1 24
$-0.03
$0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
NSSC
NSSC
Cash + ST InvestmentsLiquidity on hand
$215.5M
$115.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-261.8M
$184.8M
Total Assets
$396.9M
$212.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
NSSC
NSSC
Q4 25
$215.5M
$115.4M
Q3 25
$140.4M
$105.8M
Q2 25
$92.9M
$99.2M
Q1 25
$108.5M
$89.3M
Q4 24
$88.6M
$99.2M
Q3 24
$88.2M
$91.3M
Q2 24
$105.5M
$70.7M
Q1 24
$121.5M
$60.9M
Total Debt
IRWD
IRWD
NSSC
NSSC
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
Q2 24
$198.6M
Q1 24
$398.3M
Stockholders' Equity
IRWD
IRWD
NSSC
NSSC
Q4 25
$-261.8M
$184.8M
Q3 25
$-264.2M
$176.1M
Q2 25
$-308.2M
$168.6M
Q1 25
$-334.1M
$161.5M
Q4 24
$-301.3M
$174.2M
Q3 24
$-311.3M
$178.6M
Q2 24
$-321.7M
$178.9M
Q1 24
$-330.5M
$168.2M
Total Assets
IRWD
IRWD
NSSC
NSSC
Q4 25
$396.9M
$212.8M
Q3 25
$396.1M
$206.0M
Q2 25
$342.9M
$198.1M
Q1 25
$327.2M
$190.9M
Q4 24
$350.9M
$202.7M
Q3 24
$389.5M
$209.9M
Q2 24
$395.6M
$207.8M
Q1 24
$438.8M
$194.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
NSSC
NSSC
Operating Cash FlowLast quarter
$74.6M
$15.1M
Free Cash FlowOCF − Capex
$74.6M
$14.5M
FCF MarginFCF / Revenue
156.3%
30.1%
Capex IntensityCapex / Revenue
0.0%
1.2%
Cash ConversionOCF / Net Profit
1.12×
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$53.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
NSSC
NSSC
Q4 25
$74.6M
$15.1M
Q3 25
$47.6M
$11.6M
Q2 25
$-15.1M
$14.6M
Q1 25
$20.0M
$13.4M
Q4 24
$15.2M
$13.5M
Q3 24
$9.9M
$12.0M
Q2 24
$33.5M
$14.3M
Q1 24
$45.0M
$12.3M
Free Cash Flow
IRWD
IRWD
NSSC
NSSC
Q4 25
$74.6M
$14.5M
Q3 25
$47.6M
$11.4M
Q2 25
$-15.1M
$14.4M
Q1 25
$19.9M
$13.3M
Q4 24
$12.4M
Q3 24
$9.9M
$11.3M
Q2 24
$33.4M
$13.8M
Q1 24
$44.9M
$12.0M
FCF Margin
IRWD
IRWD
NSSC
NSSC
Q4 25
156.3%
30.1%
Q3 25
39.0%
23.3%
Q2 25
-17.7%
28.4%
Q1 25
48.4%
30.3%
Q4 24
28.8%
Q3 24
10.8%
25.8%
Q2 24
35.4%
27.4%
Q1 24
60.0%
24.3%
Capex Intensity
IRWD
IRWD
NSSC
NSSC
Q4 25
0.0%
1.2%
Q3 25
0.0%
0.4%
Q2 25
0.0%
0.5%
Q1 25
0.1%
0.1%
Q4 24
0.0%
2.6%
Q3 24
0.0%
1.5%
Q2 24
0.1%
1.1%
Q1 24
0.1%
0.7%
Cash Conversion
IRWD
IRWD
NSSC
NSSC
Q4 25
1.12×
Q3 25
1.19×
0.96×
Q2 25
-0.64×
1.26×
Q1 25
1.32×
Q4 24
6.74×
1.29×
Q3 24
2.71×
1.08×
Q2 24
1.06×
Q1 24
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons